Dr. Zibelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 Wolf St
Fl 3
Philadelphia, PA 19148Phone+1 215-334-5315Fax+1 215-334-5305
Summary
- Dr. Allison Zibelli is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Thomas Jefferson University Hospitals and Nazareth Hospital. She received her medical degree from George Washington University School of Medicine and has been in practice 22 years. She specializes in hematologic oncology and is experienced in hematologic oncology, breast cancer, cancer prevention, general medical oncology, and gynecologic and breast cancer.
Education & Training
- Thomas Jefferson UniversityCertificate, Healthcare Quality and Safety, 2013 - 2015
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1998 - 2001
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1995 - 1998
- George Washington University School of Medicine and Health SciencesClass of 1995
Certifications & Licensure
- NJ State Medical License 2018 - 2025
- PA State Medical License 1996 - 2024
- DE State Medical License 2017 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Clinical Trials
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
- S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Start of enrollment: 2006 Oct 01
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsComparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial.Melody A. Cobleigh, Stewart J. Anderson, Kalliopi P. Siziopikou, Douglas W. Arthur, Rachel Rabinovitch
Journal of Clinical Oncology. 2021-03-19 - 4 citationsCauses of Cancer Re-Admissions: A Patient-Centered ApproachAllison Zibelli, Katie Holland, Emily Wei
JCO Oncology Practice. 2020-03-27 - 15 citationsAdjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancerHarriet Eldredge-Hindy, Gary Eastwick, Pramila R. Anne, Norman G. Rosenblum, Russell J. Schilder
Journal of Contemporary Brachytherapy. 2014-09-05
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: